Çetin Zeynep, Mercan Rıdvan, Karaşahin Ömer, Tufan Abdurrahman, Öztürk Mehmet Akif
Department of Endocrinology and Metabolism, Amasya University Sabuncuoğlu Şerefeddin Training and Research Hospital, Amasya, Turkey.
Department of Internal Medicine, Division of Rheumatology, Namık Kemal University Medical Faculty Hospital, Tekirdağ, Turkey.
Arch Rheumatol. 2020 Jun 25;35(4):592-599. doi: 10.46497/ArchRheumatol.2020.7427. eCollection 2020 Dec.
This study aims to determine the frequency and risk factors of bacteriuria and urinary tract infection (UTI) in patients with primary Sjögren's syndrome (SS) and their differences from healthy individuals and rheumatoid arthritis (RA) patients.
The study included 107 female primary SS patients (mean age 50.7±11.6 years; range, 23 to 76 years), 53 healthy female control subjects (mean age 46.8±15.5 years; range 21 to 80 years), and 40 females with RA (mean age 51.7±14.2 years; range, 25 to 79 years). Participants were questioned for UTI risk factors and symptoms. Middle stream urine samples were taken and cultured. All participants were examined with urinary symptom questioning survey of American Urological Association (AUA-7).
The urine cultures were positive in 18 primary SS patients (16.8%), eight RA patients (20%), and two healthy controls (3.7%). Escherichia coli, enterococci, Klebsiella, streptococci, and candida were detected in SS patients' cultures. Extended-spectrum beta-lactamase was positive in three cultures. Asymptomatic bacteriuria was not detected in any SS patient. The highest AUA-7 score was determined in SS group (p=0.031). Nineteen SS patients had vaginal dryness symptom and their AUA-7 scores were higher than the rest of the SS group. The risk of UTI development was not different between those who had or did not have vaginal dryness.
Urinary tract infections are seen more often in SS patients rather than normal population, which may be caused by SS' urinary system effects. It is difficult to distinguish between asymptomatic bacteriuria and infection because of the underlying urinary symptoms. Clinicians must be careful in patients receiving immunosuppressive therapy due to the high frequency of UTIs.
本研究旨在确定原发性干燥综合征(SS)患者菌尿症和尿路感染(UTI)的发生率及危险因素,以及它们与健康个体和类风湿关节炎(RA)患者之间的差异。
该研究纳入了107例女性原发性SS患者(平均年龄50.7±11.6岁;范围23至76岁)、53例健康女性对照者(平均年龄46.8±15.5岁;范围21至80岁)和40例RA女性患者(平均年龄51.7±14.2岁;范围25至79岁)。对参与者询问UTI危险因素和症状。采集中段尿样本并进行培养。所有参与者均接受美国泌尿外科学会(AUA - 7)的泌尿系统症状问卷调查。
18例原发性SS患者(16.8%)、8例RA患者(20%)和2例健康对照者(3.7%)的尿培养呈阳性。在SS患者的培养物中检测到大肠杆菌、肠球菌、克雷伯菌、链球菌和念珠菌。3份培养物中广谱β - 内酰胺酶呈阳性。在任何SS患者中均未检测到无症状菌尿症。SS组的AUA - 7评分最高(p = 0.031)。19例SS患者有阴道干燥症状,其AUA - 7评分高于SS组的其他患者。有或没有阴道干燥症状的患者发生UTI的风险没有差异。
SS患者的尿路感染比正常人群更常见,这可能是由SS对泌尿系统的影响所致。由于潜在的泌尿系统症状,难以区分无症状菌尿症和感染。由于UTI发生率高,临床医生在对接受免疫抑制治疗的患者中必须谨慎。